Publications by authors named "Elizabeth Birzin"

Claim this Profile
C
Control of rat tail skin temperature regulation by estrogen receptor-beta selective ligand.
Evan E Opas, Angela Scafonas, Pascale V Nantermet, Robert R Wilkening, Elizabeth T Birzin

Maturitas· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus.
Angela Scafonas, Alfred A Reszka, Donald B Kimmel, Xiaoli Shirley Hou, Qin Su, Elizabeth T Birzin

J Steroid Biochem Mol Biol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androstene-3,5-dienes as ER-beta selective SERMs.
Timothy A Blizzard, Candido Gude, Jerry D Morgan, Wanda Chan, Elizabeth T Birzin

Bioorg Med Chem Lett· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridged androstenediol analogs as ER-beta selective SERMs.
Timothy A Blizzard, Candido Gude, Wanda Chan, Elizabeth T Birzin, Marina Mojena

Bioorg Med Chem Lett· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERalpha.
Kevin D Dykstra, Liangqin Guo, Elizabeth T Birzin, Wanda Chan, Yi Tien Yang

Bioorg Med Chem Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonist.
Mathias Z Strowski, Doreen E Cashen, Elizabeth T Birzin, Lihu Yang, Vandana Singh

Endocrinology· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists.
Dann L Parker, Dongfang Meng, Ronald W Ratcliffe, Robert R Wilkening, Donald M Sperbeck, Elizabeth T Birzin

Bioorg Med Chem Lett· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrahydrofluorenones with conformationally restricted side chains as selective estrogen receptor beta ligands.
Kenneth J Wildonger, Ronald W Ratcliffe, Ralph T Mosley, Milton L Hammond, Elizabeth T Birzin

Bioorg Med Chem Lett· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.
Lorraine Lipfert, John E Fisher, Nan Wei, Angela Scafonas, Qin Su, Elizabeth T Birzin

Mol Endocrinol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists.
Wanying Sun, Lovji D Cama, Elizabeth T Birzin, Sudha Warrier, Louis Locco

Bioorg Med Chem Lett· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androstenediol analogs as ER-beta-selective SERMs.
Timothy A Blizzard, Candido Gude, Jerry D Morgan, Wanda Chan, Elizabeth T Birzin

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 14: application of novel antagonist side chains to existing platforms.
Timothy A Blizzard, Jerry D Morgan, Wanda Chan, Elizabeth T Birzin, Lee-Yuh Pai

Bioorg Med Chem Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct agonist/antagonist functions of dehydroepiandrosterone.
Fang Chen, Kristin Knecht, Elizabeth Birzin, John Fisher, Hilary Wilkinson

Endocrinology· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain.
Timothy A Blizzard, Frank DiNinno, Helen Y Chen, Seongkon Kim, Jane Y Wu, Elizabeth T Birzin

Bioorg Med Chem Lett· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replacement of Phe6, Phe7, and Phe11 of D-Trp8-somatostatin-14 with L-pyrazinylalanine. Predicted and observed effects on binding affinities at hSST2 and hSST4. An unexpected effect of the chirality of Trp8 on NMR spectra in methanol.
Santhosh Neelamkavil, Byron Arison, Elizabeth Birzin, Jin-Jye Feng, Kuo-Hsin Chen

J Med Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs.
Qiang Tan, Timothy A Blizzard, Jerry D Morgan, Elizabeth T Birzin, Wanda Chan

Bioorg Med Chem Lett· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and binding affinities of novel SRIF-mimicking beta-D-glucosides satisfying the requirement for a pi-cloud at C1.
Angie R Angeles, Irina Neagu, Elizabeth T Birzin, Edward R Thornton, Amos B Smith

Org Lett· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans.
Jian Liu, Elizabeth T Birzin, Wanda Chan, Yi Tien Yang, Lee-Yuh Pai

Bioorg Med Chem Lett· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers.
Timothy A Blizzard, Frank Dininno, Jerry D Morgan, Helen Y Chen, Jane Y Wu, Elizabeth T Birzin

Bioorg Med Chem Lett· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains.
Timothy A Blizzard, Frank DiNinno, Jerry D Morgan, Helen Y Chen, Jane Y Wu, Elizabeth T Birzin

Bioorg Med Chem Lett· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains.
Timothy A Blizzard, Frank DiNinno, Jerry D Morgan, Jane Y Wu, Helen Y Chen, Elizabeth T Birzin

Bioorg Med Chem Lett· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 5: The SAR of dihydrobenzoxathiins containing modified basic side chains.
Qiang Tan, Elizabeth T Birzin, Wanda Chan, Yi Tien Yang, Lee-Yuh Pai

Bioorg Med Chem Lett· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
Qiang Tan, Elizabeth T Birzin, Wanda Chan, Yi Tien Yang, Lee-Yuh Pai

Bioorg Med Chem Lett· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs.
Seongkon Kim, Jane Wu, Helen Y Chen, Elizabeth T Birzin, Wanda Chan

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs.
Helen Y Chen, Seongkon Kim, Jane Y Wu, Elizabeth T Birzin, Wanda Chan

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis